Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8Prostatic Neoplasms 2Neoplasms 2Weight Loss 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Lung Neoplasms 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Metformin 7Testosterone 2Pioglitazone 2Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2Blood Pressure 2semaglutide 1maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Walking 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Topiramate 1Tirzepatide 1Sugars 1Spironolactone 1Qsymia 1Pyruvic Acid 1Pulse Wave Analysis 1Preoperative Exercise 1Phlebotomy 1Phentermine 1Pancreaticoduodenectomy 1Orchiectomy 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolic Syndrome × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡